G1 Therapeutics, Inc.
Biotechnology ResearchNorth Carolina, United States51-200 Employees
G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos.
Insights
Strategic Partnerships G1 Therapeutics has recently formed strategic alliances with Pharmacosmos and Pepper Bio, indicating a preference for collaboration within the biotech and oncology sectors. Engaging with their partnership networks could open avenues for joint ventures or supply chain enhancements.
Market Expansion The company's successful public listing in November 2022 and subsequent capital raise of over $50 million demonstrate growth momentum and financial stability, creating opportunities for expanding product lines or investing in advanced research tools.
Product Innovation G1 Therapeutics launched COSELA for small cell lung cancer, showcasing their focus on developing therapeutic solutions for oncology. There is potential to offer complementary technologies, clinical support services, or data management solutions to accelerate their R&D efforts.
Technology Adoption With a tech stack that includes enterprise tools like Microsoft Excel, DocuSign, and cloud services, G1 Therapeutics values digital infrastructure. Providing specialized biotech software, data analytics, or compliance solutions could meet their operational needs.
Industry Focus Operating in the oncology research space with a revenue of up to 10 million dollars, G1 Therapeutics offers opportunities for sales in biotech research equipment, clinical trial support, regulatory consultancy, and tailored medical technologies to support their pipeline expansion.
G1 Therapeutics, Inc. Tech Stack
G1 Therapeutics, Inc. uses 8 technology products and services including SAS, Google Hosted Libraries, Cloudflare, and more. Explore G1 Therapeutics, Inc.'s tech stack below.
- SASBusiness Intelligence
- Google Hosted LibrariesContent Delivery Network
- CloudflareContent Management System
- ShimadzuData Management
- Backbone.jsJavascript Frameworks
- jQueryJavascript Libraries
- Cloudflare Bot ManagementSecurity
- DreamHostWeb Hosting
Media & News
G1 Therapeutics, Inc.'s Email Address Formats
G1 Therapeutics, Inc. uses at least 1 format(s):
| G1 Therapeutics, Inc. Email Formats | Percentage |
| FLast@g1therapeutics.com | 93% |
| FirstLast@g1therapeutics.com | 5% |
| First.Last@g1therapeutics.com | 1% |
| FirLast@g1therapeutics.com | 1% |
Frequently Asked Questions
Where is G1 Therapeutics, Inc.'s headquarters located?
G1 Therapeutics, Inc.'s main headquarters is located at 700 Park Offices Drive Suite 200 Durham, North Carolina 27709 United States. The company has employees across 4 continents, including North AmericaAsiaEurope. What is G1 Therapeutics, Inc.'s phone number?
You can contact G1 Therapeutics, Inc.'s main corporate office by phone at +1-919-966-****
What is G1 Therapeutics, Inc.'s stock symbol?
G1 Therapeutics, Inc. is a publicly traded company; the company's stock symbol is GTHX. What is G1 Therapeutics, Inc.'s official website and social media links?
G1 Therapeutics, Inc.'s official website is g1therapeutics.com and has social profiles on LinkedInCrunchbase.What is G1 Therapeutics, Inc.'s SIC code NAICS code?
G1 Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does G1 Therapeutics, Inc. have currently?
As of February 2026, G1 Therapeutics, Inc. has approximately 51 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer, Senior Vice President Corporate Development: B. P.Chief Business Officer And Secretary: G. M.Vice President Head Of Medical Affairs: M. C.. Explore G1 Therapeutics, Inc.'s employee directory with LeadIQ.What industry does G1 Therapeutics, Inc. belong to?
G1 Therapeutics, Inc. operates in the Biotechnology Research industry. What technology does G1 Therapeutics, Inc. use?
G1 Therapeutics, Inc.'s tech stack includes SASGoogle Hosted LibrariesCloudflareShimadzuBackbone.jsjQueryCloudflare Bot ManagementDreamHost. What is G1 Therapeutics, Inc.'s email format?
G1 Therapeutics, Inc.'s email format typically follows the pattern of FLast@g1therapeutics.com. Find more G1 Therapeutics, Inc. email formats with LeadIQ. When was G1 Therapeutics, Inc. founded?
G1 Therapeutics, Inc. was founded in 2008.
Company Overview
- Headquarters
- 700 Park Offices Drive Suite 200 Durham, North Carolina 27709 United States
- Phone number
- +1-919-966-****
- Website
- g1therapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- GTHX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2008
- Employees
- 51-200
Media & News
Funding & Financials
- $1M$10M
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $1M$10M
G1 Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M
Company Leadership
B. P.Chief Financial Officer, Senior Vice President Corporate Development
G. M.Chief Business Officer And Secretary- M. C.Vice President Head Of Medical Affairs
- H. K.Vp, Commercial Counsel
J. Z.Senior Director, Biostatistics
Employee Directory
- B. Q.Lifesciences R&d Director
- C. S.Independent Board Director
- D. W.Senior Director, Clinical Scientist
- J. H. M.Associate Director, Product Development Outsourcing
- J. R.Director, Statistical Programming
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
